Novo Nordisk Licenses Nanexa's PharmaShell In Deal Worth Up To EUR 1.165 Bln

(RTTNews) - Nanexa AB, a Swedish drug delivery platform company developing long-acting injectable drugs, announced that it has entered into a global exclusive license and collaboration agreement with Novo Nordisk A/S (NVO) for the use of it's PharmaShell technology platform for c